ArticleVaccines2019

In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination.

Shigetaka Shimodaira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.